The treatment of advanced neuroblastoma. Results of the spanish neuroblastoma study group (SNSG) studies

European Journal of Cancer

Volumn 31, Issue 4, 1995, Pages 642-645

  Castel, V ^a,g   Garcia Miguel, P ^b,g   Melero, C ^d,g   Navajas, A ^c,g   Navarro, S ^e,g   Molina, J ^d,g   Badal, M D ^f,g  

^a HOSPITAL INFANTIL LA FE   (Spain)

^b H La Paz   (Spain)

^c H Cruces   (Spain)

^d 12 de Octubre Madrid Spain ^*

^e HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^f Hospital Clínico ^*  (Spain)

^g Radiotherapy Hospital La Fe Valencia Spain ^*  (Spain)

Author keywords

ABMT; neuroblastoma; stage III neuroblastoma; stage IV neuroblastoma

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; TENIPOSIDE; VINCRISTINE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; NEUROBLASTOMA; PRIORITY JOURNAL; SURVIVAL RATE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; HUMAN; INFANT; NEOPLASM STAGING; NEUROBLASTOMA; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE;

EID: 0028999857     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00072-Q     Document Type: Article

References (18)

1. A proposed staging for children with neuroblastoria. Children's Cancer Study Group A
2. Neuroblastoma. Resultados del protocole N-I-87
3. Reporting results of cancer treatment
4. Cisplatin ototoxicity in children: a practical grading system
5. TNM classification of pediatric tumors
6. Improvement in survival after excision of primary tumor in stage III neuroblastoma
7. Surgical management of stage III and IV neuroblastoma: resection before or after chemotherapy?
8. Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastoma
9. Stage III neuroblastoma over 1 year of age at diagnosis improved survival with intensive multimodality therapy including multiple alkylating agents
10. Treatment of stage III neuroblastoma with emphasis on intensive induction chemotherapy. A report from the Neuroblastoma Group of the Spanish Society of Pediatric Oncology
11. Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26
12. Sequential cisplatin VM26 and vincristine/cyclophosphamide/doxorubicin in metastatic neuroblastoma: an effective alternating non-cross-resistant regimen?
13. Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen)
14. The role of chemotherapy in the treatment of children with neuroblastoma stage IV The GPO (German Pediatric Oncology Society) experience
15. Standard-dose and high-dose peptichemio and cisplatin in children with disseminated poor-risk neuroblastoma: two studies by the Italian Cooperative Group for Neuroblastoma
16. International criteria for diagnosis staging, and response to treatment in patients with neuroblastoma
17. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment